Nigelle 5 in Prevention of Influanza
NCT04989101
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
500
Enrollment
OTHER
Sponsor class
Conditions
COVID-19 Acute Respiratory Distress Syndrome
Interventions
DRUG:
Nigella
Sponsor
Hôpital Universitaire Sahloul